KOPRAN
Back to Cashflow Statement
|
KOPRAN Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹26 Cr | ₹0.99 Cr | ₹-20 Cr | ₹123 Cr | ₹-35 Cr |
What is the latest Cash Flow from Financing Activities ratio of KOPRAN ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹26 Cr |
| Mar2024 | ₹0.99 Cr |
| Mar2023 | ₹-20 Cr |
| Mar2022 | ₹123 Cr |
| Mar2021 | ₹-35 Cr |
How is Cash Flow from Financing Activities of KOPRAN Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹26 Cr | 2,515.57 | |
| Mar2024 | ₹0.99 Cr | Positive | |
| Mar2023 | ₹-20 Cr | Negative | |
| Mar2022 | ₹123 Cr | Positive | |
| Mar2021 | ₹-35 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹748.4 Cr | 3% | 13.9% | -30.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,681.0 Cr | 2.4% | -2.5% | -7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,324.0 Cr | 3.9% | 2.6% | 3.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,466.0 Cr | 2.5% | 4.1% | 12.3% | Stock Analytics | |
| CIPLA | ₹118,524.0 Cr | 1.3% | 0.6% | -1.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,711.0 Cr | -1.2% | -1.5% | -9.1% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | 3% |
13.9% |
-30.5% |
| SENSEX | -0.3% |
-0.9% |
6.3% |
You may also like the below Video Courses